Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada · Delayed Price · Currency is CAD 0.1000
-0.0050 (-4.76%)
Jan 20, 2026, 3:11 PM EST
Pharmala Biotech Holdings Revenue
Pharmala Biotech Holdings had revenue of 206.44K CAD in the quarter ending November 30, 2025, with 260.30% growth. This brings the company's revenue in the last twelve months to 754.64K, up 121.87% year-over-year. In the fiscal year ending August 31, 2025, Pharmala Biotech Holdings had annual revenue of 605.50K, down -41.51%.
Revenue (ttm)
754.64K
Revenue Growth
+121.87%
P/S Ratio
15.15
Revenue / Employee
n/a
Employees
n/a
Market Cap
11.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | 605.50K | -429.80K | -41.51% |
| Aug 31, 2024 | 1.04M | 503.29K | 94.60% |
| Aug 31, 2023 | 532.00K | 453.93K | 581.44% |
| Aug 31, 2022 | 78.07K | - | - |
| Aug 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| COSCIENS Biopharma | 12.61M |
| Innovotech | 4.46M |
| Glow Lifetech | 1.88M |
| Kane Biotech | 574.87K |
| Britannia Life Sciences | 260.58K |